Simultaneous uncoupled expression and purification of the Dengue virus NS3 protease and NS2B co-factor domain

被引:18
|
作者
Shannon, A. E. [1 ]
Chappell, K. J. [1 ]
Stoermer, M. J. [2 ]
Chow, S. Y. [2 ]
Kok, W. M. [2 ]
Fairlie, D. P. [2 ]
Young, P. R. [1 ,2 ]
机构
[1] Univ Queensland, Sch Chem & Mol Biosci, St Lucia, Qld 4072, Australia
[2] Univ Queensland, Inst Mol Biosci, Div Chem & Struct Biol, St Lucia, Qld 4072, Australia
基金
英国医学研究理事会; 澳大利亚国家健康与医学研究理事会;
关键词
Dengue virus; Protease; NS2B-NS3; Cofactor inhibitor; YELLOW-FEVER VIRUS; WEST-NILE-VIRUS; ENZYMATIC CHARACTERIZATION; STRUCTURAL PROTEINS; VIRAL REPLICATION; CLEAVAGE SITES; IN-VITRO; POLYPROTEIN; MUTAGENESIS; FLAVIVIRUS;
D O I
10.1016/j.pep.2015.11.022
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Dengue Virus (DENV) infection is responsible for the world's most significant insect-borne viral disease. Despite an increasing global impact, there are neither prophylactic nor therapeutic options available for the effective treatment of DENV infection. An attractive target for antiviral drugs is the virally encoded trypsin-like serine protease (NS3pro) and its associated cofactor (NS2B). The NS2B NS3pro complex is responsible for cleaving the viral polyprotein into separate functional viral proteins, and is therefore essential for replication. Recombinant expression of an active NS2B-NS3 protease has primarily been based on constructs linking the C-terminus of the approximately 40 amino acid hydrophilic cofactor domain of NS2B to the N-terminus of NS3pro via a flexible glycine linker. The resulting complex can be expressed in high yield, is soluble and catalytically active and has been used for most in vitro screening, inhibitor, and X-ray crystallographic studies over the last 15 years. Despite extensive analysis, no inhibitor drug candidates have been identified yet. Moreover, the effect of the artificial linker introduced between the protease and its cofactor is unknown. Two alternate methods for bacterial expression of non-covalently linked, catalytically active, NS2B-NS3pro complex are described here along with a comparison of the kinetics of substrate proteolysis and binding affinities of substrate-based aldehyde inhibitors. Both expression methods produced high yields of soluble protein with improved substrate proteolysis kinetics and inhibitor binding compared to their glycine-linked equivalent. The non-covalent association between NS2B and NS3pro is predicted to be more relevant for examining inhibitors that target cofactor-protease interactions rather than the protease active site. Furthermore, these approaches offer alternative strategies for the high yield co-expression of other protein assemblies. (C) 2015 Elsevier Inc. All rights reserved.
引用
收藏
页码:124 / 129
页数:6
相关论文
共 50 条
  • [11] West Nile Virus NS2B/NS3 Protease As An Antiviral Target
    Chappell, K. J.
    Stoermer, M. J.
    Fairlie, D. P.
    Young, P. R.
    CURRENT MEDICINAL CHEMISTRY, 2008, 15 (27) : 2771 - 2784
  • [12] In-silico Design of Curcumin Analogs as Potential Inhibitors of Dengue Virus NS2B/NS3 Protease
    Roney, Miah
    Huq, A. K. M. Moyeenul
    Aluwi, Mohd Fadhlizil Fasihi Mohd
    Tajuddin, Saiful Nizam
    JOURNAL OF COMPUTATIONAL BIOPHYSICS AND CHEMISTRY, 2023, : 645 - 653
  • [13] The Inhibition of NS2B/NS3 Protease: A New Therapeutic Opportunity to Treat Dengue and Zika Virus Infection
    Starvaggi, Jose
    Previti, Santo
    Zappala, Maria
    Ettari, Roberta
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (08)
  • [14] Dengue protease activity: the structural integrity and interaction of NS2B with NS3 protease and its potential as a drug target
    Phong, Wai Y.
    Moreland, Nicole J.
    Lim, Siew P.
    Wen, Daying
    Paradkar, Prasad N.
    Vasudevan, Subhash G.
    BIOSCIENCE REPORTS, 2011, 31 (05) : 399 - 409
  • [15] Dengue virus serotypic replacement of NS3 protease or helicase domain causes chimeric viral attenuation but can be recovered by a compensated mutation at helicase domain or NS2B, respectively
    Teramoto, Tadahisa
    JOURNAL OF VIROLOGY, 2023, 97 (08)
  • [16] In silico identification of novel allosteric inhibitors of Dengue virus NS2B/NS3 serine protease
    Da Costa, Renato A.
    Da Rocha, Joao A. P.
    Pinheiro, Alan S.
    Da Costa, Andreia S. S.
    Da Rocha, Elaine C. M.
    Josino, Luiz P. C.
    Goncalves, Arlan da silva
    Lima, Anderson H. L.
    Brasil, Davi S. B.
    JOURNAL OF THE SERBIAN CHEMICAL SOCIETY, 2022, 87 (06) : 693 - 706
  • [17] Recent advances in natural products as potential inhibitors of dengue virus with a special emphasis on NS2b/NS3 protease
    Saqallah, Fadi G.
    Abbas, Manal A.
    Wahab, Habibah A.
    PHYTOCHEMISTRY, 2022, 202
  • [18] Repurposing of investigational cancer drugs: Early phase discovery of dengue virus NS2B/NS3 protease inhibitors
    Saleem, Hafiza N.
    Kousar, Summara
    Jiskani, Ammar Hassan
    Sohail, Iqra
    Faisal, Amir
    Saeed, Muhammad
    ARCHIV DER PHARMAZIE, 2023, 356 (11)
  • [19] Binding mode of the activity-modulating C-terminal segment of NS2B to NS3 in the dengue virus NS2B-NS3 protease
    de la Cruz, Laura
    Chen, Wan-Na
    Graham, Bim
    Otting, Gottfried
    FEBS JOURNAL, 2014, 281 (06) : 1517 - 1533
  • [20] Activation of dengue protease autocleavage at the NS2B-NS3 junction by recombinant NS3 and GST-NS2B fusion proteins
    Wu, CF
    Wang, SH
    Sun, CM
    Hu, ST
    Syu, WJ
    JOURNAL OF VIROLOGICAL METHODS, 2003, 114 (01) : 45 - 54